Intellia Therapeutics, Inc. (NTLA)

15.46 +1.43 (+10.19%) USD  |  NASDAQ  |  Jan 22, 14:00
More

Intellia Therapeutics Proceeds from Stock Option Exercised (Annual)

Proceeds from Stock Option Exercised (Annual) Chart

View Proceeds from Stock Option Exercised (Annual) for NTLA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Proceeds from Stock Option Exercised (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Proceeds from Stock Option Exercised (Annual) Range, Past 5 Years

View Proceeds from Stock Option Exercised (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Proceeds from Stock Option Exercised (Annual) Benchmarks

View Proceeds from Stock Option Exercised (Annual) Benchmarks
Start Trial
Beam Therapeutics, Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Pacific Biosciences of California, Inc. Upgrade
Twist Bioscience Corp. Upgrade